This year’s Heart Rhythm Society (HRS) meeting was a great opportunity to take the pulse of electrophysiologists on how they’re incorporating Farapulse and Medtronic’s PulseSelect into their practices, whether these catheters are living up to the hype as they transition to broad commercial use, what technologies they’re displacing as adoption ramps, and how the PFA competitive landscape could evolve over the next 12-18 months as new devices enter the field.
To help us put this year’s meeting takeaways in perspective and think through how the PFA revolution is playing out, we’ve enlisted the help of Dr. Sunil Kapur, a leading electrophysiologist at Brigham and Women's Hospital and Assistant Professor of Medicine at Harvard Medical School.